Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vectans Pharma is a European-based pharmaceutical company with a primary focus to target unmet needs in patients with oral pathologies through the acquisition and worldwide commercial development of innovative targeted therapeutics. Our current portfolio includes Sitavig® and Loramyc®, 2 products approved by FDA and several authorities in Europe, and 1 proprietary innovative galenic technology : Lauriad®.

List your booth number for exhibitions, ask us